The 
INTRODUCTION
Expression of many herpesvirus genes is coordinately regulated and sequentially ordered in a cascade fashion. Gene regulation during herpes simplex type 1 (HSV-1) infection in tissue culture has been most extensively analyzed. HSV-1 genes are classified as immediate-early (IE), early or late, depending on their kinetics of expression and response to inhibitors of macromolecular synthesis (1, 2) . The five IE genes are transcribed at the onset of infection in the absence of de-novo protein synthesis and at least some of the IE polypeptides are required for the normal regulation of the later classes of genes (for reviews see [3] [4] [5] . Of the five IE gene products, Vmwl75 (expressed from gene IE-3) is perhaps the most important since its inactivation results in failure to transcribe early and late genes and an apparent overexpression of the IE genes (6, 7) . Thus Vmwl75 is directly or indirectly required for the normal expression of all other HSV-1 genes.
Varicella-zoster virus (VZV), another member of the neurotropic alphaherpesvirinae subfamily, is genetically closely related to HSV-1 (8, 9) . However, in contrast to HSV-1, the knowledge of gene regulation during VZV infection is still rudimentary. The major reason for this is the poor growth of VZV in the available tissue culture systems which produce predominantly cell associated virus with low titer stocks. Four VZV IE products have been detected in infected cells by cycloheximide reversal experiments (10) . The gene product of VZV genes 62 and 71 (the identical gene is present in both copies of the short repeat regions ( Figure 1A) ) has a predicted Mr of 140.000D (VZV 140k) and shares considerable predicted amino acid identity with HSV-1 Vmwl75. For several reasons 140k is believed to be the functional counterpart of Vmwl75; HSV-1 mutants with lesions in Vmwl75 can be complemented by either transfected plasmids or transformed cell lines which express VZV 140k (11, 12) and moreover a recombinant HSV-1 virus (HSV-140) with both copies of the Vmwl75 coding sequences replaced by the homologous gene 71 ORF is viable in tissue culture (13) .
In transfection assays at least, the VZV 140k protein functions as a powerful transcriptional activator of viral and selected cellular gene expression (14) (15) (16) and autoregulates its own gene 62 promoter (17) . The predicted primary sequence of 140k can be divided into five regions on the basis of similarity to the corresponding Vmwl75 protein (18) . The integrity of highly conserved region 2 is required for the transactivation and repression phenotypes of Vmwl75 (19, 20) and an insertion mutation in 140k region 2 inhibits these same functions (17) suggesting that VZV 140k and HSV-1 Vmwl75 regulate gene expression by related mechanisms. However the two proteins are not entirely interchangeable for autoregulation as Vmwl75 can substitute for 140k in the downregulation of the VZV gene 62 promoter in transient transfection assays whereas the 140k protein does not repress the HSV-1 IE-3 promoter in the reciprocal experiment (17) .
In the case of Vmwl75, its autoregulatory function is mediated at least in part by the formation of a complex between Vmwl75 and a specific sequence fitting the Vmwl75 binding consensus ATCGTnnnnnYSG (21, 22 and references therein) found at the cap site of the IE-3 promoter (23) . This complex is presumed to downregulate transcription either by sterically blocking the movement of RNA polymerase II or by displacing an essential transcriptional factor such as TF11D. The DNA binding domain of Vmwl75 has been mapped by a variety of different techniques to a region encompassing the C-terminal protion of region 1 and the whole of region 2 (19, 20, 24, 25) . This domain of Vmwl75 has been expressed as a stable, functionally separable domain in bacteria (25, 21) , exists as a dimer in solution (21) and binds DNA with a specificity similar to that of the intact protein (25, 21) . Both intact Vmwl75 and its isolated DNA binding domain bend DNA when occupying the IE-3 promoter binding site (26) . The biological significance of this DNA bending is unclear but it may be relevant to the mechanism of autoregulation by Vmwl75.
The corresponding DNA binding domain of VZV 140k has been expressed as a trpE fusion polypeptide in bacteria (encompassing codons 417 to 647) (27) and binds to sequences in the vicinities of both cap sites proposed for its own gene 62 promoter (28, 12) . Degenerate versions of the HSV-1 Vmwl75 binding consensus are contained within these recognized sequences. In addition, the same group demonstrated that the DNA binding domain fusion polypeptide of the homologous IE 180 protein of pseudorabies virus (PRV) interacted with its promoter in a similar manner (27) . These findings suggest that the formation of a specific complex between an EE protein and its own gene promoter may be a common mechanism used by alphaherpesvirinae to autoregulate transcription of an essential IE gene.
We sought to investigate whether differences in the behaviour of 140k and Vmwl75 in autoregulation assays could be explained by variations in their DNA binding specificities. We have expressed the region 2 domain of 140k as a non-fusion protein in E.coli (codons 417 to 646) and analyzed its activities in DNA binding experiments in comparison with the corresponding Vmwl75 DNA binding domain. Our results confirm those of Wu and Wilcox (27) and extend them to identify in more detail the sites that are bound by the VZV 140k DNA binding domain. A mutational analysis indicated that the VZV 140k DNA binding domain was less specific in its DNA binding requirements than that of Vmwl75, and failed to bend DNA at its binding sites. These differences in DNA binding properties may be relevant to the slight differences in their biological properties. In addition, we have defined the limits of the VZV 140k DNA binding domain to residues 472-633 using a deletion analysis. This is significantly smaller than the minimal DNA binding domain of HSV-1 Vmwl75 (21,25). Plasmids, bacteria and bacteriophage  Plasmid pV17 is a derivative of pi40 (a plasmid including the  entire VZV gene 62, see ref 28 ) with a 12 bp EcoRI linker oligonucleotide inserted at codon 418. Plasmid p585T7a was derived from the T7 expression vector p585.4 (21) by removal of the EcoRI site (by cutting, Klenow fUling-in of 5' overhangs followed by religation) prior to co-ligation of an NcoI-EcoRI adaptor oligonucleotide (21) and the EcoRI-Hindm multiple cloning region (mcr) fragment of PUC19 between the Ncol and Hindm sites of p585.4 at the initiation of translation. In addition, the Sphl-PvuH fragment of the vector was removed by cutting with SphI and PvuTI, Klenow end-filling, followed by blunt-end ligation, to increase the number of restriction enzyme sites available for cloning in the p585T7a vector. All plasmids were constructed and maintained in E.coli strain AH5. For the expression experiments, plasmids were transformed into E.coli strain BL21 (DE3) pLysS (29) .
MATERIALS AND METHODS
Bacteriophage M13 containing wild type and mutant forms of the HSV-1 IE-3 cap site region (21) were transfected into E.coli strain JM101. The JM101 host bacterium was used for all subsequent growth and maintenance of M13 bacteriophage.
Preparation of intact Vmwl75 protein
Crude nuclear extracts containing HSV-1 Vmwl75 protein were prepared from HeLa cells transfected with the plasmid pi75 as previously described (30) .
Construction of the 140k DNA binding domain expression plasmids Plasmid p585T7aVT2 was constructed by cutting the plasmid pV17 with BstEH, filling-in of the 5' overhang with Klenow, before cutting again with EcoRI. The resulting EcoRI-BstEII fragment (containing the 140k codons 417 to 646) was isolated and inserted between the adaptor EcoRI site and the Smal site of the vector p585T7a. The NcoI-EcoRI adaptor oligonucleotides had been synthesized so as to maintain the 140k peptide reading frame (which is initiated at the ATG of the Ncol site). BamHI digestion, followed by isolation and religation of the plasmid construct removed DNA sequences between the BamHI site of the mcr and the BamHI she in the translational termination region. The sequences at the 5' and 3' ends of the insertion were confirmed by direct plasmid sequencing. Plasmid p585T7aVT2 encodes a 257 residue peptide, designated VT2, consisting of 4 amino acids derived from the amino-terminal junction region sequence (MAEF); the VZV 140k residues 417 to 646; 3 residues from the mcr (QGI) to its carboxy-terminal side; followed by 20 residues encoded by vector DNA 3' to the BamHI site. Plasmid p585T7aVT2X was derived from p585T7aVT2 by insertion of an Xbal linker oligonucleotide containing stop codons in all three reading frames into the BamHI site of p585T7aVT2-this removed 19 vector encoded residues from the distal end of the expressed protein that are present in the VT2 polypeptide. The 238 residue expression product of plasmid p585T7aVT2X is designated VT2X.
Plasmids expressing 140k DNA binding domain deletion polypeptides were constructed using appropriate restriction enzyme sites (as indicated in Figure 8A ) for cloning into the mcr of plasmid p585T7a. The cloning proceedures ensured that all constructs were in frame with the ATG translation initiation codon of the vector. The predicted 5' and 3' boundaries of the expression regions were confirmed by direct plasmid DNA sequencing.
Expression and partial purification of the 140k DNA binding domains T7 expression plasmids were transformed into E. coli host strain BL21 (DE3) pLysS and maintained as glycerol stocks. Bacterial colonies from freshly streaked plates containing ampicillin at 100/ig/ml and chloramphenicol at 25/tg/ml were innoculated into YT-broth containing the above concentrations of antibiotics, and grown shaking at 37°C until the OD 4J0 was 0.5. IPTG was then added to a final concentration of 0. lmM and induction followed at 26°C for a further 2 hours. Bacteria were harvested by centrifugation and resuspended in 1% culture volume of resuspension buffer (50mM Hepes pH 7.2, lOOmM NaCl, 6mM CHAPS, lmM PMSF and 0. lmM DTT) and frozen at -20°C. Thawed bacteria were disrupted by sonication for 4x 10 sees, at 80-90 W (using a Dawe soniprobe Type7532A) on ice prior to addition of DNase I (to 24/tg/ml); RNase A (to 100/tg/ml) and MgCl 2 (to 6mM). After 30 mins incubation at 4°C, NaCl was added to 1M final concentration followed by addition of polymin P to 0.2%. The resulting suspensions were centrifuged at 15K for 15 mins. in me Sorvall SS34 rotor. Supernatants were made up to 35% saturation with ammonium sulphate and the precipitated protein pellets dissolved in 0.2% original culture volume of resuspension buffer. These solutions were clarified by centrifugation and the supernatants containing the partially purified extracts stored at -20°C. A partially purified extract of the HSV-1 Vmwl75 DNA binding domain peptide I9X (31) prepared by this method was kindly provided by K. E. Allen.
Polyacrylamide gel analysis of expressed proteins E.coli BL21 bacterial extracts containing the induced viral proteins were analyzed by electrophoresis through a 12.5% SDS polyacrylamide gel using the Biorad miniprotean II kit and visualized by staining with Coomassie blue.
Preparation of probes for DNA binding analyses
End-labelled restriction fragment probes used for DNA binding analyses on the HSV-1 EE-3 promoter and the VZV gene 62 promoter regions were prepared as follows:-The UP6 probe, including the gene 62 mRNA start site at nucleotide -287 proposed by Felser (12) was isolated as a Sall-Rsal fragment, spanning nucleotides -409 to -188 of the gene 62 promoter, from the plasmid pl40 (28) . The BT probe, spanning the mRNA start site at nucleotide +1 located experimentally by McKee (28) was isolated as a Xhol-Bgin fragment encompassing residues -130 to +57 of the gene 62 promoter from the plasmid pl40BT, a derivative of pl40 with a BglH site inserted at nucleotide +57 (28) . The IE-3 probes contained a strong Vmwl75 binding site (23) located at the cap site of the HSV-1 IE-3 gene and were isolated as either an Aval-BamHI fragment (coordinates -18 to +27) or as an EcoRI-BamHI fragment (coordinates -108 to +27) from the plasmid pIE-3CAT (20) . The probes were constructed by initially cutting the plasmids with either Sail, Xhol or BamHI respectively, end-labelling with Klenow and a 32 ? dATP, followed by digestion with the second enzyme as appropriate. The labelled fragments were eluted from acrylamide gels and purified by ethanol precipitation. A specific oligonucleotide probe (UP6 oligo) was synthesized corresponding to the region of the gene 62 promoter spanning the proposed mRNA start site at -287, by annealing complementary single stranded 35mer oligonucleotides carrying sequences derived from -311 to -283 of the gene 62 promoter flanked by non-gene 62 sequences giving rise to 5' Aval and 3' BamHI sticky ends.
Klenow end-filling, in the presence of a 32 P dATP yielded the end-labelled UP6 oligo probe.
Comparative gel retardation analysis of the IE-3 consensus binding site containing single point mutations used probes prepared by the 'prime cut' method (32) taking measures to obtain sets of probes of equal specific activity. In each series of probe preparations, a wild type control was prepared in an identical manner at the same time.
DNA bending analysis of the gene 62 promoter sites used derivatives of the plasmid pBEND2 (33) which includes a tandemly repeated sequence (containing 17 different restriction sites) with unique Xbal and Sail cloning sites between the two repeats. Plasmids pBENDU and pBENDP were constructed by insertion of the gene 62 promoter UP6 oligo (including gene 62 bases -311 to -283) and an Rsal-Rsal gene 62 promoter fragment (-23 to +50) respectively into the Sail site of pBEND2 by blunt end ligation following Klenow end-filling of any 5' overhangs. The direct repeats in these pBEND plasmids, contain amongst others, BglTI, Xhol and BamHI sites; cutting with any of these enzymes produced DNA fragments of 184 bp from pBENDU and 218 bp from pBENDP. These fragments were Klenow end-labelled and isolated as before to produce two groups of three probes with 140k binding sites in circularly permuted positions with respect to their ends.
Gel retardation assays
Appropriate amounts of partially purified DNA binding domain peptides or nuclear extracts were incubated on ice with O.lng of end-labelled DNA fragment probes or freshly made 'prime cut' probes in buffer giving final concentrations of lOmM Tris.HCl pH8.0, lmM EDTA, lOOmM NaCl, 1/tg polydl.polydC, 0.1 % NP40 and 50/xg/ml BSA. After incubation for 20 mins, 0.2 volumes of loading buffer (lOmM Tris.HCl pH8.0, lmM EDTA, lOmM mercaptoethanol, 0.1% CHAPS, 50% glycerol and 0.25mg/ml bromophenol blue) was added to each incubation mix. Samples were applied to a non-denaturing 4% polyacrylamide gel with 0.5XTBE running buffer and run at 150V at 4°C for 3 hrs. Complexes and unbound probe were detected by autoradiography of dried gels. Where appropriate, the extent of binding was determined by scintillation counting of dried gel slices corresponding to the positions of free and bound probe previously located by autoradiography. To allow for background values contributed by complexes with E.coli proteins (which were visually undetectable), dried gel slices from control lanes were also cut out and counted. These values, which were negligable, were subtracted from the sample counts, to allow calculation of the percentage of total probe bound.
DNase I footprinting assays Site specific protection of DNA fragments from partial DNase I digestion by the 140k VT2 and Vmwl75 I9X DNA binding domain peptides was determined by modification of the method of Galas and Schmitz (34) . DNA binding reactions contained 4ng of target DNA labelled with ^P at one 5' end and suitable amounts of bacterial extracts, incubated in buffer giving final concentrations of lOmM Tris.HCl pH 7.5, lmM EDTA, lOmM mercaptoethanol, 0.1 % CHAPS and lOOmM NaCl. After a 20 minute incubation at 22°C, MgCl 2 ( to lOmM), CaCl 2 (to 2mM) and 0.0625 units of DNase I were added, mixed and incubated for a further 60 seconds, after which time 20/tg of proteinase K in 100/tl of a buffer containing 1% SDS, 100/tg/ml tRNA, 200mM NaCl, 20mM EDTA was added and the reaction incubated at 50°C for a further 20 mins. The DNA was then extracted by phenol, chloroform and ethanol precipitation and resuspended in formamide dye mix (lmg/ml xylene cyanol, lmg/ml bromophenol blue and lOmM EDTA in deionized formamide). In addition, a G+A Maxam-Gilbert sequencing reaction (35) was carried out on 4ng of the particular end-labelled probe used in each DNase I footprinting experiment to provide a sequencing ladder for orientation of the footprint. Samples were applied to 8% polyacrylamide/8M urea sequencing gels for BT and UP6 probes and 12% polyacrylamide/8M urea gels for the shorter HSV-1IE-3 Aval-BamHI probe, and electrophoresed at 40W for 2-3 hrs. as required. Gels were dried prior to visualization of DNase I protection patterns by autoradiography. expressed in isolation and found to have a similar binding specificity to that of the intact protein (21, 25, 31) . Our intention was to express the equivalent region of the homologous VZV IE protein 140k, encompassing its DNA binding domain, in order to study its DNA binding characteristics for comparison with those of the HSV-1 Vmwl75 DNA binding domain. Wu and Wilcox (27) had previously expressed in E.coli the 140k codons 417 to 647, proceeded by 323 codons derived from the trpE ORF, and had found that this fusion pepti.de bound DNA in a sequencespecific manner. We chose to express a similar region of 140k as a non-fusion polypeptide to eliminate the possible influence of a large stretch of non-homologous E.coli coding region on the properties of the fusion protein. Our non-fusion polypeptide spanned VZV 140k codons 417 to 646 and mainly consisted of the highly conserved region 2, designated on the basis of homology between the HSV-1 Vmwl75 and the VZV 140k proteins (18) . The C-terminal portion of region 1, poorly conserved in the related IE proteins of the a-herpesviruses, was also included in our expressed peptide; the role played by these additional residues is not fully understood but deletion analysis on the 140k DNA binding domain found them to be necessary for the production of a clear DNase I footprint but not for binding in gel retardation assays (see below).
RESULTS

Cloning
The DNA binding domain of 140k was cloned into the T7 expression vector p585T7a, as described in detail in the materials and methods section. The resulting plasmids p585T7aVT2 and p585T7aVT2X both contained the gene 62 coding region for 140k residues 417-646 inclusive, differing from each other only by the extent of vector coding sequences to the 3' of this gene 62 region. The expressed polypeptides will be referred to as VT2 and VT2X respectively. Both of these 140k DNA binding domain peptides were expressed to high levels and were clearly visible on SDS-PAGE gels stained with Coomassie blue (Figure 2) . The VT2X version of VT2 was constructed due to the finding that
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VT2 VT2X (31) . The VT2X polypepti.de was expressed at slightly higher levels and had an increased DNA binding affinity as compared to the VT2 version (data not shown); otherwise these two proteins could be considered identical. Partially purified extracts of bacterially expressed VT2 and VT2X were obtained by ammonium sulphate precipitation ( Figure 2 ) and were used for all subsequent DNA binding analyses.
The 140k DNA binding domain specifically recognizes multiple gene 62 promoter sequences in DNase I footprinting assays Initial experiments using the VT2X peptide with the UP6 probe (described in materials and methods) indicated the formation of defined DNA:protein complexes. With increasing amounts of protein, higher order complexes containing more than one VT2X peptide were observed (results not shown, but see Figure 5 ). We investigated the interaction of VT2 on a number of different probes by DNase I footprinting. Typical results (Figure 4 ) indicated that VT2 bound (with apparently similar affinity) to several sites within the gene 62 promoter region (summarized in Figure 3) , and that many of these sites contained sequences similar to the HSV-1 Vmwl75 binding site consensus (Figure 3 ).
VZV ORF 62 Promoter:
-apo Characteristically these sites were flanked by regions of DNase I hypersensitivity (Figure 4) . between VT2 and Vmwl75 binding sites in detail. Firstly we confirmed that the VZV DNA binding domain could interact with the Vmwl75 binding site in the IE-3 promoter. Incubation of the VT2X peptide with an IE-3 probe (coordinates -108 to +27) gave specific proteur.DNA complexes ( Figure 5A , lane 2) and again additional multiple complexes arose on titration of the VT2X peptide (data not shown) as noted earlier with the gene 62 promoter probes. Lesser exposures of the gel in Figure 5A show three such multiple VT2X complexes on the IE-3 probe (lane 2). A high-resolution DNase I footprinting analysis on the AvalBamHI HSV-1 IE-3 fragment probe (-18 to +27) provided verification that the 140k DNA binding domain specifically recognized the HSV-1 IE-3 Vmwl75 consensus binding site. The VT2 peptide protected, albeit faintly, both halves of this bipartite Vmwl75 consensus site (21) from DNase I digestion ( Figure 5B ). DNase I hypersensitivity was again induced at the edges of the protected sequences as the amount of VT2 extract present increased. The footprint produced at this site by the VZV 140k VT2 DNA binding domain differed in several respects to that produced by protein I9X, the corresponding domain of Vmwl75 ( Figure 5C ). VT2 induced greater DNase I hypersensitivity at the 5' side of the binding site but less complete protection within Having established that the 140k DNA binding domain recognized the HSV-1 IE-3 promoter binding site, we decided to compare the binding specificities of the HSV-1 Vmwl75 and VZV 140k proteins. Our intention was to identify differences in die binding specificities of diese two homologous IE proteins that might account for their opposing functional effects on the EE-3 promoter seen in transfection assays (17) . An extensive mutagenesis of die IE-3 binding site had been performed previously for an analysis of die sequence requirements for Vmwl75 binding (21) . We utilized the progeny M13 phage resulting from this study to isolate 'prime cut' Aval-BamHI IE-3 fragment (-18 to +27) probes, containing single point mutations at all positions throughout this IE-3 consensus binding site. The probes were used in gel retardation experiments widi the VT2 bacterial extract to determine die VT2 binding specificity for die IE-3 binding site. The percentage efficiency of VT2 binding to each mutant probe was determined widi respect to binding to die wild-type probe. The results are summarized in histogram form in the bottom section of Figure 6 widi die previously determined binding profile for the Vmwl75 DNA binding domain peptide I9X (21, 31) shown above. It is apparent diat die 140k DNA binding domain has an overall reduced binding specificity for diis IE-3 consensus binding site compared to diat of die Vmwl75 DNA binding domain and appears to be virtually insensitive to point mutations in me 3' portion of die bipartite sequence.
Both intact HSV-1 Vmwl75 and its isolated DNA binding domain have very low affinities for the VZV gene 62 promoter VT2 binding sites
We had demonstrated diat die 140k DNA binding domain specifically recognized die HSV-1 IE-3 promoter binding site and were interested to determine whedier die HSV-1 Vmwl75 DNA binding domain would interact widi die 140k binding sites identified in die VZV gene 62 promoter. Approximately equivalent amounts of VT2X and die corresponding Vmwl75 DNA binding domain peptide I9X (31) were incubated widi IE-3 promoter and gene 62 promoter probes and die resultant complexes analyzed by gel retardation assays. We found diat complexes specific to I9X were undetectable widi die UP6 oligo probe ( Figure 5A , lane 8) which spans die gene 62 promoter U site (strongly protected by VT2 in DNase I footprinting). I9X incubation widi die BT probe, which includes die 140k binding sites P1-P5, also gave no obvious specific complexes ( Figure 5A, lane 13) . On repetition of diis analysis widi greater amounts of I9X extract, faint protein.DNA complexes were detected widi die gene 62 promoter BT probe (data not shown). To verify diat die binding results obtained for I9X reflect die situation widi intact Vmwl75, nuclear extracts from HeLa cells, transfected eimer widi or widiout plasmid pi75 (30) were also incubated with die same probes as above. The only protein:DNA complex specific to intact Vmwl75 produced in diis gel retardation analysis was widi die HSV-1 IE-3 probe (seen in lane 5 of Figure 5A , marked by die horizontal arrow), die complexes obtained widi die UP6 oligo and BT gene 62 promoter probes being identical for nuclear extracts widi or widiout Vmwl75 ( Figure 5A, lanes 10 and 9, 15 and 14 respectively) . We conclude diat intact HSV-1 Vmwl75 and its isolated DNA binding domain botii have greatly reduced affinities for die VT2 binding sites in die VZV gene 62 promoter, compared to die binding observed widi die VZV 140k DNA binding domain. So aldiough several of die VT2 binding sites in die gene 62 promoter show sequence similarity to die Vmwl75 binding consensus, die degree of homology of die sites is insufficient to allow recognition of uiese gene 62 promoter sites by die comparatively specific Vmwl75 protein. These results are in agreement widi diose obtained from die above specificity comparison between VZV VT2 and HSV-1 I9X DNA binding domain peptides, which found VT2 to be generally less sequence-specific than die Vmwl75 DNA binding domain. In addition, HSV-1 I9X protection of die strong VT2 binding site U in die VZV gene 62 promoter was undetectable using DNase I footprinting analysis of the UP6 fragment probe (data not shown).
Binding of the 140k DNA binding domain does not induce DNA bending at its gene 62 promoter binding sites
The isolated DNA binding domain of HSV-1 Vmwl75 causes a significant DNA bend in the immediate vicinity of the Vmwl75 binding sequence spanning the HSV-1 IE-3 mRNA start she (26) . This may play a role in the autoregulatory function of Vmwl75. Since we had found that the 140k DNA binding domain recognizes sites bearing similarity to the Vmwl75 consensus binding sequence, and moreover, specifically recognizes this IE-3 promoter binding site, it was of interest to determine whether VT2 binding would induce a similar conformational change on the DNA at its binding sites in the vicinities of both proposed gene 62 mRNA start sites. The method used to detect DNA bending depends on the principle that a bend near the end of a restriction fragment causes a less pronounced reduction in electrophoretic mobility as compared to a bend in the middle. In order to test for VT2 induced DNA bending, we cloned regions of the gene 62 promoter, spanning the U site and also the P4/P5 140k binding sites (identified by the DNase I footprinting analysis) into the pBEND2 plasmid (33) . Probe fragments derived from the resultant pBENDU and pBENDP plasmids, by cutting with either BgUI, Xhol or BamHI, contained respectively a single or pair of VT2 binding sites at circularly permuted positions within each set of three probes ( Figure 7B ). The VT2 DNA binding domain peptide VT2 was incubated with each of the probes and the resulting complexes separated on polyacrylamide gels. An example of a typical bending analysis is shown in Figure 7A ; there is no significant difference in mobility of the primary protein:DNA complex within each set of three probes derived from either the pBENDU or pBENDP plasmids. Thus the 140k DNA binding domain does not appear to induce DNA bending at the VT2 binding sites in the vicinities of the proposed gene 62 mRNA start sites.
The DNA binding activity of VZV 140k resides within residues 472 to 633 as determined by gel retardation analysis VZV 140k DNA binding domain deletion polypeptides were expressed to high levels in E.coli and partially purified as described for the VT2 polypeptide. Details of the expressed regions are given in Figure 8A . The DNA binding ability of each deletion polypeptide was assayed by gel retardation analysis, an example of which is shown in Figure 8B . Polypeptides VT1 to VT5 gave well defined protein:DNA complexes while VT7 (residues 472 -594) and VT11 (residues 504 -646) failed to bind to the DNA probe ( Figure 8B , lanes 7 and 8 respectively) even at greatly increased protein concentrations (data not shown). From this deletion analysis we conclude that the minimal DNA binding domain of the 140k protein lies within residues 472 to 633. The VT2 peptide was selected for all of the above DNA binding analyses for several reasons. The longer VT1 peptide was less stable than VT2 and tended to degrade in the bacterial extracts. The shorter peptides VT4 and VT5 gave good DNA binding in gel retardation assays, but, for reasons unknown, failed to yield DNase I footprints at the VT2 binding sites described above. Despite this lack of footprinting, the specificity of binding of the shorter VT4 peptide was very similar to that shown in Figure 6B using VT2 (data not shown). Although the VT3 peptide bound to DNA in both types of assays, it is interesting that the mobility of the VT3 complex is greater than expected ( Figure 8B , lane 4). It is possible that the deletion is encroaching upon an important part of the protein and altering the conformation of the complex.
DISCUSSION
The results in this paper demonstrate that a portion of the VZV 140k protein comprising the C-terminal portion of region 1 and all of the conserved region 2 can be expressed in isolation in E. coli as a non-fusion DNA binding domain peptide that interacts with multiple sequences in the VZV gene 62 promoter. Several We chose to utilize the isolated DNA binding domain of the VZV 140k protein for these analyses due to the difficulties encountered in a previous attempt to detect sequence-specific DNA binding by the intact 140k polypeptide (39) . The sequencespecific DNA binding function of HSV-1 Vmwl75 resides in a discrete domain of the polypeptide comprising mainly the highly conserved region 2 sequences. This Vmwl75 domain, when expressed in bacteria or liberated from the intact protein by proteolytic cleavage, is able to bind DNA with a very similar affinity and specificity to the intact polypeptide (25, 21, 24) . Therefore it is reasonable to assume that the binding properties of the 140k DNA binding domain presented here reflect those of the full 140k polypeptide.
Autoregulation of the HSV-1 IE-3 gene requires (at least in transfection assays) interaction of Vmwl75 with a specific binding site in the IE-3 promoter (36) . Similarly the 140k DNA binding domain specifically recognizes its own gene 62 promoter and by analogy to the situation with Vmwl75, this interaction is implicated in the autoregulatory function of 140k. The ability to bind multiple sites in the gene 62 promoter had been recognized previously by Wu and Wilcox (27) using a 140k region 2 domain fusion protein; our analyses utilizing a non-fusion 140k DNA binding domain polypeptide (VT2) confirm and extend this observation. The VT2 peptide exhibits slightly differing affinities for the numerous binding sites in the gene 62 promoter, but preferential binding to any single site was not apparent.
Binding to multiple sites is unlikely to be a feature specific to the autoregulatory function of 140k, since DNase I footprinting analysis of the HSV-1 glycoprotein gD promoter, which is activated by 140k in transfection assays (15) , identifies multiple sites of VT2 protection and extensive DNase I hypersensitivity (data not shown). In addition, the homologous IE protein of PRV (IE 180) binds multiple sequences with limited homology in the AdML and hsp70 promoters and such binding is necessary for the activation of these promoters by the PRV IE 180 protein (37) .
No obvious 140k binding consensus could be derived from the gene 62 promoter binding sites, although several of the more strongly protected sequences contain homologies to the 5' portion of the Vmwl75 binding consensus (21, 22) . Interestingly two such sites are located in the immediate vicinities of both the transcription initiation site at +1 and the proposed transcription initiation site further upstream at -287. A thorough mutational analysis of the gene 62 promoter would be necessary to determine whether these, or any other specific binding sites, are required for the downregulation of this promoter by the 140k protein.
Our examination of the specificity of VT2 for a Vmwl75 consensus binding site found that sequences in the 3' portion of the consensus site were unimportant for VT2 binding. It is possible that the VT2 binding sites may have their own distinct 3' sequence, but none is apparent for die sites identified in this study. The results presented here show the 140k DNA binding domain has a lower DNA binding specificity compared to the equivalent domain of Vmwl75. This is reflected in the high number and the variety of the sequences protected by VT2 in the gene 62 ( Figure 3 ) and HSV-1 gD promoters and also the high level of non-specific binding to the pBEND2 probe ( Figure 7A, lane 8) . This low specificity of DNA binding might perhaps explain the promiscuous transactivating phenotype of 140k in transfection assays (15, 16) . It can be predicted from the low binding specificity of the 140k DNA binding domain, that the intact 140k protein would have a low promoter selectivity; 140k could perhaps function by activating sub-optimally utilized RNA polymerase II promoters in a similar manner to that previously suggested for the homologous PRV IE 180 protein (38) . The 140k protein is also a more potent transactivator than Vmwl75 in transfection assays (15, 16) . This is not merely a function of the relative strengths of the HSV-1 IE-3 and VZV gene 62 promoters (39) but could be attributable to either the relative strengths of their activating domains (unknown at present) or alternatively multiple 140k interactions with the promoter may have an additive effect, enhancing the efficiency of activation.
Our results suggest that DNA binding to a sequence over the transcription initiation site is not sufficient for autoregulation as protein VT2 specifically interacts with the HSV-1 IE-3 consensus site yet evidence from transfection assays (17) and also the recombinant HSV-140 virus (13) suggests that intact 140k fails to repress this IE-3 promoter. In addition, although Vmwl75 is equally as effective as 140k in the downregulation of the gene 62 promoter in transfection assays (17) , intact Vmwl75 and also its isolated DNA binding domain displayed greatly reduced affinities for the binding sites therein, compared to the 140k DNA binding domain. Slight differences between the sequences of the specific binding sites found in the region of the IE-3 and gene 62 mRNA start sites may account for this functional inconsistency. Alternatively the precise positioning of the IE-3 site with respect to the mRNA start site may not be correct for downregulation of this promoter by the 140k protein, as a close correlation has been observed between Vmwl75 mediated autorepression and the stereo-specific or distance-dependent placement of the IE-3 binding site and die TATA box (discussion of reference 40). It seems that the mechanism of autoregulation of the gene 62 promoter is more complicated than DNA binding alone and is likely to involve interactions with other proteins.
Of possible functional significance are the alterations of DNA conformation induced by binding of the VT2 peptide, made apparent by the strong sites of DNase I hypersensitivity in the gene 62 promoter (Figure 4) . The purified DNA binding domain of Vmwl75 significantly bends the DNA at its binding sites (26) , whereas VT2 induced bending was not detected in a corresponding analysis. This lack of DNA bending at individual VT2 binding sites and also the extensive nature of the hypersensitivity pattern suggest mat the conformational effects may extend along the whole promoter, induced by multiple VT2 peptides binding to numerous sites. If this transpires to be the case for binding of the intact 140k protein during VZV infection, numerous possible functional implications of such a broad-ranging conformational effect can be envisaged, including modification of the interactions of transcription factors with DNA or with other proteins, or clearing the promoter of non-specific DNA binding proteins.
Despite the equivalent roles played by the HSV-1 Vmwl75 and VZV 140k proteins in dieir respective viruses and the high level of sequence homology between their DNA binding domains, numerous differences in their DNA binding characteristics are apparent and are likely to have an important bearing on their activities during infection.
